InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53
United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
John Patrick Shannon Jr
5 Jan 2026
See Remarks
Sold after exercise
24,907
$7.08
$176.26K
John Patrick Shannon Jr
13 Nov 2025
See Remarks
Sold after exercise
23,242
$7.46
$173.40K
Jeffrey W Sherman
28 Aug 2025
Director
Sold after exercise
42,232
$7.92
$334.52K
Steven Prestrelski
22 Feb 2022
Chief Scientific Officer
Sold after exercise
11,228
$2.42
$27.16K
Show all 68 transactions →

What was left out

Form 4 filings counted 156
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 33
Sales straight out of an exercise 4
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 17,798,318
History held since 5 Oct 2021